Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The pathogenesis of essential thrombocythemia.

Current opinion in hematology - 1 Sept 2011

Beer Philip A

Abstract excerpt

PURPOSE OF REVIEW: The identification of new mutations continues to further our understanding of the molecular pathogenesis of essential thrombocythemia and related disorders, and offers opportunities for improvements in diagnosis, risk stratification and disease classification. RECENT FINDINGS: Molecular lesions in essential thrombocythemia affect two distinct pathways: cytokine signaling and transcriptional...

Topics

Join the communities discussing this publication.

Adaptor Proteins, Signal Transducing
Dioxygenases
Intracellular Signaling Peptides and Proteins
Isocitrate Dehydrogenase
Janus Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Myeloproliferative Disorders

Receptors, Thrombopoietin

Thrombocythemia, Essential

Source

Identifiers

PMID: 21825979
DOI: 10.1097/MOH.0b013e3283497f54

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The pathogenesis of essential thrombocythemia.PMID 21825979Read ↗

The Roles of Genetic and Epigenetic Abnormalities in Essential ThrombocythemiaSemantic proximity Read ↗

New advances in the pathogenesis and therapy of essential thrombocythemia.Semantic proximity Read ↗

Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision MedicineSemantic proximity Read ↗

Genetic Risk Assessment in Myeloproliferative Neoplasms.Semantic proximity Read ↗

Polycythemia vera and essential thrombocythemia: new developments in biology with therapeutic implications.Semantic proximity Read ↗

Recent advances in understanding myelofibrosis and essential thrombocythemiaSemantic proximity Read ↗

Sailing in deceptive calm: Navigating the undercurrents of essential thrombocythaemia.Semantic proximity Read ↗

Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.Semantic proximity Read ↗

The new WHO classification for essential thrombocythemia calls for revision of available evidences.Semantic proximity Read ↗

[Essential thrombocythemia: molecular pathophysiology and treatment].Semantic proximity Read ↗

Molecular and genetic bases of myeloproliferative disorders: questions and perspectives.Semantic proximity Read ↗

Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.